Literature DB >> 12493754

Polo-like kinase 1 and Chk2 interact and co-localize to centrosomes and the midbody.

Lyuben Tsvetkov1, Xingzhi Xu, Jia Li, David F Stern.   

Abstract

Chk2 is a protein kinase intermediary in DNA damage checkpoint pathways. DNA damage induces phosphorylation of Chk2 at multiple sites concomitant with activation. Chk2 phosphorylated at Thr-68 is found in nuclear foci at sites of DNA damage (1). We report here that Chk2 phosphorylated at Thr-68 and Thr-26 or Ser-28 is localized to centrosomes and midbodies in the absence of DNA damage. In a search for interactions between Chk2 and proteins with similar subcellular localization patterns, we found that Chk2 coimmunoprecipitates with Polo-like kinase 1, a regulator of chromosome segregation, mitotic entry, and mitotic exit. Plk1 overexpression enhances phosphorylation of Chk2 at Thr-68. Plk1 phosphorylates recombinant Chk2 in vitro. Indirect immunofluorescence (IF) microscopy revealed the co-localization of Chk2 and Plk1 to centrosomes in early mitosis and to the midbody in late mitosis. These findings suggest lateral communication between the DNA damage and mitotic checkpoints.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12493754     DOI: 10.1074/jbc.M211202200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Restoration of an absent G1 arrest and protection from apoptosis in embryonic stem cells after ionizing radiation.

Authors:  Yiling Hong; Peter J Stambrook
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-27       Impact factor: 11.205

2.  Centrosomal Chk2 in DNA damage responses and cell cycle progression.

Authors:  Amnon Golan; Elah Pick; Lyuben Tsvetkov; Yasmine Nadler; Harriet Kluger; David F Stern
Journal:  Cell Cycle       Date:  2010-07-01       Impact factor: 4.534

Review 3.  Centrosomes in the DNA damage response--the hub outside the centre.

Authors:  Lisa I Mullee; Ciaran G Morrison
Journal:  Chromosome Res       Date:  2016-01       Impact factor: 5.239

Review 4.  Repair of topoisomerase I-mediated DNA damage.

Authors:  Yves Pommier; Juana M Barcelo; V Ashutosh Rao; Olivier Sordet; Andrew G Jobson; Laurent Thibaut; Ze-Hong Miao; Jennifer A Seiler; Hongliang Zhang; Christophe Marchand; Keli Agama; John L Nitiss; Christophe Redon
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2006

5.  The spindle assembly checkpoint regulates the phosphorylation state of a subset of DNA checkpoint proteins in Saccharomyces cerevisiae.

Authors:  Céline Clémenson; Marie-Claude Marsolier-Kergoat
Journal:  Mol Cell Biol       Date:  2006-10-23       Impact factor: 4.272

6.  The forkhead-associated domain protein Cep170 interacts with Polo-like kinase 1 and serves as a marker for mature centrioles.

Authors:  Giulia Guarguaglini; Peter I Duncan; York D Stierhof; Tim Holmström; Stefan Duensing; Erich A Nigg
Journal:  Mol Biol Cell       Date:  2004-12-22       Impact factor: 4.138

Review 7.  Mitotic DNA Damage Response: At the Crossroads of Structural and Numerical Cancer Chromosome Instabilities.

Authors:  Samuel F Bakhoum; Lilian Kabeche; Duane A Compton; Simon N Powell; Holger Bastians
Journal:  Trends Cancer       Date:  2017-02-28

8.  Female infertility in PDE3A(-/-) mice: polo-like kinase 1 (Plk1) may be a target of protein kinase A (PKA) and involved in meiotic arrest of oocytes from PDE3A(-/-) mice.

Authors:  Weixing Shen; Faiyaz Ahmad; Steven Hockman; John Ma; Hitoshi Omi; Nalini Raghavachari; Vincent Manganiello
Journal:  Cell Cycle       Date:  2010-12-01       Impact factor: 4.534

9.  Differential regulation of centrosome integrity by DNA damage response proteins.

Authors:  Rekha Rai; Ashwini Phadnis; Sharda Haralkar; Rajendra A Badwe; Hui Dai; Kaiyi Li; Shiaw-Yih Lin
Journal:  Cell Cycle       Date:  2008-05-14       Impact factor: 4.534

Review 10.  Mitotic crisis: the unmasking of a novel role for RPA.

Authors:  Rachel William Anantha; James A Borowiec
Journal:  Cell Cycle       Date:  2009-02-21       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.